Product Wiki · Recalls · U.S. CPSC

Recall 25223 — Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs

U.S. CPSC · United States · 2025-04-10

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. CPSC
Recall identifier
25223
Date of alert
2025-04-10
Country / jurisdiction
United States
Risk type
recall
Product category
consumer_product
Reported risk: This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back. Hazards: The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Primary source: https://www.cpsc.gov/Recalls/2025/Kramer-Laboratories-Recalls-Safetussin-Max-Str

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.